3SBio Inc. Schedules Second Quarter 2010 Unaudited Financial Results
(Nasdaq: SSRX) (“3SBio” or “the Company”), a leading
company focused on researching, developing, manufacturing and marketing
biopharmaceutical products, today announced that it will release unaudited
financial results for the second quarter ended
August 17, 2010
Following the earnings announcement, 3SBio’s senior management will host a
conference call at
quarter financial results and recent business activity. The conference call
may be accessed using the dial-in numbers below:
Conference ID: 92606068 Local dial-in: China landline 800-819-0121 China mobile 400-620-8038 Hong Kong 852-2475-0994 International toll-free dial-in: Hong Kong 800930346 United Kingdom 080-8234-6646 United States 1-866-519-4004 International toll dial-in: 65 6723 9381 Replay - Conference ID: 92606068
A telephone replay will be available two hours after the call until
International dial-in: 61-2-8235-5000 United States dial-in: 1-866-214-5335
A replay of the webcast will be available within one hour after the
conclusion of the call.
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on
researching, developing, manufacturing and marketing biopharmaceutical
products, primarily in
web at http://www.3SBio.com .
For more information, please contact: Investor Contacts Bo Tan Chief Financial Officer 3SBio Inc. Tel: +86-24-2581-1820 Email: ir@3SBio.com Tom Folinsbee Director of Investor Relations 3SBio Inc. Tel: +852-8191-6991 Email: ir@3SBio.com
SOURCE 3SBio Inc.